Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Other hematologic neoplasm 2Gynecologic 2Genitourinary 2Head & Neck 1CNS 1

Conditions

Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid 1

Interventions

Cyclophosphamide 678Cytarabine 576fludarabine 410fludarabine phosphate 387venetoclax 310Methotrexate 297Rituximab 283Azacitidine 264Busulfan 248Whole-Body Irradiation 220Etoposide 215Filgrastim 214Peripheral Blood Stem Cell Transplantation 211Mycophenolic Acid 206Tacrolimus 196Dexamethasone 191Granulocyte Colony-Stimulating Factor 182Vincristine 173Melphalan 173Decitabine 163Cyclosporine 146Daunorubicin 139Antilymphocyte Serum 137Idarubicin 134Imatinib Mesylate 127Lenalidomide 116Doxorubicin 109Radiotherapy 108Stem Cell Transplantation 107Clofarabine 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diagnosis × Other hematologic neoplasm × Clear all
NCT05787951 2023-03-28

Frequency and Risk Factors of Acute Myeloid Leukemia

Assiut University

Unknown
200 enrolled
Other hematologic neoplasm

Leukemia, Myeloid

NCT04562818 2020-09-24

Mexico APL

Instituto Nacional de Cancerologia de Mexico

Completed
360 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡